# Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination

> **NCT01880125** · PHASE1 · COMPLETED · sponsor: **Yungjin Pharm. Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Tramadol HCI/Acetaminophen

## Key facts

- **NCT ID:** NCT01880125
- **Lead sponsor:** Yungjin Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01880125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01880125, "Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01880125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*